For the second time in two years, Medtronic has pulled capsules from the market over a fault that could obstruct patients’ ...

The attack has affected the company’s ability to manufacture products and to process and ship customers’ orders, and there is ...

Valerie Dixon arrives at Cleveland Diagnostics as the company works to commercialize its prostate cancer test in the U.S.

With Amulet 360, Abbott aims to capture share from Boston Scientific in the market for devices that seal the heart’s left ...

The attack affected global operations, and its full scope is still being determined, the medical device maker said in a ...

Building on its image-guided therapy platform, Philips will work with academic collaborators to create a robot capable of ...

Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.

Hospitals can use automated controllers in inventory while waiting for service from J&J’s Abiomed business to ensure patients ...

The agency published a discussion paper this week as it considers the “unique risks” and potential promise of generative AI ...

The Food and Drug Administration hailed the potential of the first-of-its-kind device to counter the U.S. phlebotomist ...

Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.

Jonathan Pratt will take over the role on Sept. 1. The announcement ends Qiagen’s nearly 10-month search for a new chief ...